Nezam Afdhal
Nezam Afdhal
Professor of Medicine, Harvard Medical School
Dirección de correo verificada de bidmc.harvard.edu
Título
Citado por
Citado por
Año
Liver cirrhosis
D Schuppan, NH Afdhal
The Lancet 371 (9615), 838-851, 2008
20842008
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ...
New England Journal of Medicine 370 (20), 1889-1898, 2014
18512014
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
N Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ...
New England Journal of Medicine 370 (16), 1483-1493, 2014
15082014
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
P Marcellin, E Gane, M Buti, N Afdhal, W Sievert, IM Jacobson, ...
The Lancet 381 (9865), 468-475, 2013
13792013
Response-guided telaprevir combination treatment for hepatitis C virus infection
KE Sherman, SL Flamm, NH Afdhal, DR Nelson, MS Sulkowski, ...
New England Journal of Medicine 365 (11), 1014-1024, 2011
10012011
Telaprevir for previously treated chronic HCV infection
JG McHutchison, MP Manns, AJ Muir, NA Terrault, IM Jacobson, ...
New England Journal of Medicine 362 (14), 1292-1303, 2010
9142010
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ...
Gastroenterology 139 (1), 120-129. e18, 2010
9062010
Evaluation of liver fibrosis: a concise review
NH Afdhal, D Nunes
American Journal of Gastroenterology 99 (6), 1160-1174, 2004
8622004
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease
M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ...
Gastroenterology 149 (3), 649-659, 2015
7702015
Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection
GR Foster, N Afdhal, SK Roberts, N Bräu, EJ Gane, S Pianko, E Lawitz, ...
New England Journal of Medicine 373 (27), 2608-2617, 2015
7612015
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
HS Conjeevaram, MW Fried, LJ Jeffers, NA Terrault, TE Wiley–Lucas, ...
Gastroenterology 131 (2), 470-477, 2006
5772006
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
JG McHutchison, G Dusheiko, ML Shiffman, M Rodriguez-Torres, S Sigal, ...
New England Journal of Medicine 357 (22), 2227-2236, 2007
5052007
Thrombocytopenia associated with chronic liver disease
N Afdhal, J McHutchison, R Brown, I Jacobson, M Manns, F Poordad, ...
Journal of hepatology 48 (6), 1000-1007, 2008
4952008
Diagnosis and quantitation of fibrosis
DS Manning, NH Afdhal
Gastroenterology 134 (6), 1670-1681, 2008
4722008
The natural history of hepatitis C
NH Afdhal
Seminars in liver disease 24 (S 2), 3-8, 2004
4332004
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study
NH Afdhal, DT Dieterich, PJ Pockros, ER Schiff, ML Shiffman, ...
Gastroenterology 126 (5), 1302-1311, 2004
4332004
IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C
TJ Urban, AJ Thompson, SS Bradrick, J Fellay, D Schuppan, KD Cronin, ...
Hepatology 52 (6), 1888-1896, 2010
4282010
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ...
Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017
4232017
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised …
E Lawitz, JP Lalezari, T Hassanein, KV Kowdley, FF Poordad, AM Sheikh, ...
The Lancet infectious diseases 13 (5), 401-408, 2013
4052013
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
MJ Koziel, D Dudley, N Afdhal, A Grakoui, CM Rice, QL Choo, ...
The Journal of clinical investigation 96 (5), 2311-2321, 1995
3951995
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20